|
|
|
Insider
Information: |
Sullivan Louis |
Relationship: |
Director |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
178,473 |
|
Indirect Shares
|
20,185 |
|
|
Direct
Value |
$10,177,347 |
|
|
Indirect Value
|
$2,011,839 |
|
|
Total
Shares |
198,658 |
|
|
Total
Value |
$12,189,186 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
5
|
Stock
price went up :
|
0
|
3
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
1.5
|
Percentage
Gain/Loss : |
0.0%
|
-4.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
ANI Pharmaceuticals Inc |
ANIP |
Director |
2011-08-15 |
47,898 |
2003-07-17 |
0 |
Premium* |
|
3M Co |
MMM |
Director |
2006-05-09 |
1,722 |
2006-05-09 |
20,185 |
Premium* |
|
Bristol-Myers Squibb Co |
BMY |
Director |
2005-04-29 |
8,399 |
2004-04-23 |
0 |
Premium* |
|
Equifax Inc |
EFX |
Director |
2004-05-05 |
6,033 |
2004-05-05 |
0 |
Premium* |
|
Henry Schein Inc |
HSIC |
Director |
2016-03-04 |
14,096 |
2005-03-18 |
0 |
Premium* |
|
United Therapeutics Corp |
UTHR |
|
2024-05-03 |
13,060 |
2007-12-11 |
0 |
Premium* |
|
Emergent Biosolutions Inc. |
EBS |
Director |
2023-05-25 |
87,265 |
2010-05-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
169 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 7 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
HSIC |
Henry Schein Inc |
Director |
|
2015-03-27 |
4 |
D |
$138.80 |
$54,132 |
D/D |
(390) |
19,408 |
0 |
- |
|
HSIC |
Henry Schein Inc |
Director |
|
2015-03-09 |
4 |
D |
$138.97 |
$92,693 |
D/D |
(667) |
19,798 |
0 |
- |
|
MMM |
3M Co |
Director |
|
2003-08-11 |
4 |
A |
$141.90 |
$36,894 |
I/I |
260 |
7,684 |
|
- |
|
MMM |
3M Co |
Director |
|
2003-09-12 |
4 |
A |
$142.14 |
$4,833 |
I/I |
34 |
7,718 |
|
- |
|
HSIC |
Henry Schein Inc |
Director |
|
2015-11-17 |
4 |
S |
$153.89 |
$2,407,750 |
D/D |
(15,622) |
17,463 |
0 |
- |
|
HSIC |
Henry Schein Inc |
Director |
|
2016-03-02 |
4 |
S |
$168.50 |
$1,978,374 |
D/D |
(11,735) |
12,993 |
0 |
- |
|
HSIC |
Henry Schein Inc |
Director |
|
2016-03-02 |
4 |
D |
$168.93 |
$106,933 |
D/D |
(633) |
16,830 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2015-06-18 |
4 |
S |
$185.60 |
$2,783,973 |
D/D |
(15,000) |
0 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2015-06-18 |
4 |
D |
$185.78 |
$5,573,400 |
D/D |
(30,000) |
0 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2021-05-11 |
4 |
D |
$194.30 |
$5,829,000 |
D/D |
(30,000) |
9,420 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
|
|
2022-10-03 |
4 |
AS |
$211.56 |
$150,208 |
D/D |
(710) |
12,180 |
0 |
% |
|
UTHR |
United Therapeutics Corp |
|
|
2022-05-26 |
4 |
S |
$223.37 |
$1,419,781 |
D/D |
(6,310) |
11,100 |
0 |
% |
|
UTHR |
United Therapeutics Corp |
|
|
2022-09-02 |
4 |
S |
$225.98 |
$1,109,550 |
D/D |
(4,910) |
12,180 |
0 |
% |
|
UTHR |
United Therapeutics Corp |
|
|
2022-11-01 |
4 |
AS |
$230.28 |
$161,196 |
D/D |
(700) |
12,180 |
0 |
% |
|
UTHR |
United Therapeutics Corp |
|
|
2023-03-01 |
4 |
AS |
$245.10 |
$171,570 |
D/D |
(700) |
12,180 |
0 |
% |
|
UTHR |
United Therapeutics Corp |
|
|
2024-05-03 |
4 |
S |
$257.39 |
$1,333,285 |
D/D |
(5,160) |
13,060 |
0 |
% |
|
UTHR |
United Therapeutics Corp |
|
|
2023-02-01 |
4 |
AS |
$261.33 |
$182,931 |
D/D |
(700) |
12,180 |
0 |
% |
|
UTHR |
United Therapeutics Corp |
|
|
2023-01-03 |
4 |
AS |
$276.26 |
$193,382 |
D/D |
(700) |
12,180 |
0 |
% |
|
UTHR |
United Therapeutics Corp |
|
|
2022-12-01 |
4 |
AS |
$279.89 |
$195,923 |
D/D |
(700) |
12,180 |
0 |
% |
|
169 Records found
|
|
Page 7 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|